Globus Medical Inc [GMED] stock is trading at $83.42, up 2.11%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The GMED shares have gain 0.64% over the last week, with a monthly amount glided 2.86%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Globus Medical Inc [NYSE: GMED] stock has seen the most recent analyst activity on December 02, 2024, when Morgan Stanley upgraded its rating to a Overweight and also boosted its price target to $100 from $83. Previously, Wells Fargo upgraded its rating to Overweight on August 07, 2024, and elevated its price target to $78. On May 20, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $80 on the stock. BTIG Research upgraded its rating to a Buy but stick to its price target of $60 on March 18, 2024. ROTH MKM initiated its recommendation with a Buy and recommended $75 as its price target on October 20, 2023. Stifel upgraded its rating to Buy for this stock on September 19, 2023, but kept the price target unchanged to $61. In a note dated March 30, 2023, Canaccord Genuity upgraded an Buy rating on this stock but restated the target price of $67.
Globus Medical Inc [GMED] stock has fluctuated between $49.14 and $87.22 over the past year. Currently, Wall Street analysts expect the stock to reach $85 within the next 12 months. Globus Medical Inc [NYSE: GMED] shares were valued at $83.42 at the most recent close of the market. An investor can expect a potential return of 1.89% based on the average GMED price forecast.
Analyzing the GMED fundamentals
Globus Medical Inc [NYSE:GMED] reported sales of 2.48B for the trailing twelve months, which represents a growth of 63.10%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.02 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 81.85 points at the first support level, and at 80.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 84.56, and for the 2nd resistance point, it is at 85.71.
Ratios To Look Out For
For context, Globus Medical Inc’s Current Ratio is 2.51. Also, the Quick Ratio is 1.64, while the Cash Ratio stands at 0.76. Considering the valuation of this stock, the price to sales ratio is 4.58, the price to book ratio is 2.79 and price to earnings (TTM) ratio is 125.84.
Transactions by insiders
Recent insider trading involved Huller Kelly, SVP, GC, Corporate Secretary, that happened on Dec 02 ’24 when 2500.0 shares were sold. Officer, Huller Kelly completed a deal on Dec 02 ’24 to buy 2500.0 shares. Meanwhile, Director Davidar David D sold 13254.0 shares on Nov 21 ’24.
